Kura Oncology's market cap is currently ―. The company's EPS TTM is $-2.083; its P/E ratio is -9.43; Kura Oncology is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	$ -38.20M	$ -36.79M	$ -31.57M	$ -27.53M
EBITDA	-	$ -40.75M	$ -38.56M	$ -32.94M	$ -27.94M
Net Income Common Stockholders	$ -42.79M	$ -38.60M	$ -37.17M	$ -31.93M	$ -31.73M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 423.96M	$ 452.59M	$ 476.98M	$ 405.90M	$ 437.99M
Total Assets	$ 448.94M	$ 473.77M	$ 494.74M	$ 423.61M	$ 456.31M
Total Debt	$ 17.20M	$ 17.42M	$ 13.04M	$ 13.54M	$ 14.02M
Net Debt	$ -406.76M	$ -435.17M	$ -463.94M	$ -392.36M	$ -423.96M
Total Liabilities	$ 51.66M	$ 43.83M	$ 35.06M	$ 30.79M	$ 36.03M
Stockholders Equity	$ 397.27M	$ 429.94M	$ 459.68M	$ 395.18M	$ 420.28M
Cash Flow	-
Free Cash Flow	-	$ -29.05M	$ -25.71M	$ -35.91M	$ -26.54M
Operating Cash Flow	$ -34.31M	$ -29.03M	$ -25.62M	$ -35.87M	$ -26.53M
Investing Cash Flow	$ 42.20M	$ 8.56M	$ -46.33M	$ 11.13M	$ -47.32M
Financing Cash Flow	$ 691.00K	$ 84.00K	$ 94.01M	-	$ 34.71M

Currency in USD

Kura Oncology Earnings and Revenue History

Income Statement >

Kura Oncology Debt to Assets

Balance Sheet >

Kura Oncology Cash Flow

Cash Flow >

Kura Oncology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing